Studies have indicated a specific increase in the expression of SIRT2 in liver NK cells induced in mice with liver cancer, suggesting that SIRT2 promotes the activity of liver NK cells in response to hepatocellular carcinoma (HCC). The gene discussed is SIRT2; the disease is liver cancer.